A BILL 
To improve activities for the gathering of data on, and the 
tracking of, new variants of COVID–19. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Tracking COVID–19 
4
Variants Act’’. 
5
SEC. 2. FINDINGS. 
6
Congress finds that— 
7
20:37 Feb 28, 2021
H791
2 
•HR 791 IH
(1) new variants of SARS–CoV–2 are being 
1
identified around the world and in the United 
2
States; 
3
(2) identifying new variants of SARS–CoV–2 
4
and analyzing the epidemiology of variants are crit-
5
ical to the continued response to the COVID–19 
6
pandemic and efforts to prepare for future 
7
pandemics; 
8
(3) national sequence-based surveillance will en-
9
able the United States to best identify new variants; 
10
and 
11
(4) the United States is conducting sequence- 
12
based surveillance of approximately 0.3 percent of 
13
COVID–19 cases, lagging far behind other nations. 
14
SEC. 3. GUIDANCE. 
15
The Secretary of Health and Human Services (re-
16
ferred to in this Act as the ‘‘Secretary’’), acting through 
17
the Director of the Centers for Disease Control and Pre-
18
vention, shall issue national guidance to support scientific 
19
collaboration relating to viral sequencing as a key strategy 
20
to the COVID–19 response activities of the United States, 
21
including guidance related to the sharing of specimens ob-
22
tained from patients, the secure sharing of information 
23
about such specimens necessary for an effective public 
24
20:37 Feb 28, 2021
H791
3 
•HR 791 IH
health response to COVID–19, and the appropriate use 
1
of viral sequence data derived from such specimens. 
2
SEC. 4. FUNDING FOR GENOMIC SEQUENCING, ANALYTICS, 
3
AND DISEASE SURVEILLANCE. 
4
(a) IN GENERAL.—The Secretary, acting through the 
5
Director of the Centers for Disease Control and Preven-
6
tion, shall establish and implement a program to strength-
7
en and expand activities related to genomic sequencing, 
8
analytics, and disease surveillance. 
9
(b) USE OF FUNDS.—In implementing the program 
10
under subsection (a), the Secretary, acting through the 
11
Director of the Centers for Disease Control and Preven-
12
tion, shall— 
13
(1) conduct and expand activities, including 
14
supporting the Advanced Molecular Detection Pro-
15
gram, to sequence the genome of circulating strains 
16
of the SARS–CoV–2 virus, to identify mutations in 
17
the SARS–CoV–2 virus, and to survey the circula-
18
tion and transmission of variant strains of the 
19
SARS–CoV–2 virus; 
20
(2) provide technical assistance and guidance 
21
and award grants or cooperative agreements to 
22
State, local, Trial, or territorial public health depart-
23
ments to increase the capacity of such departments 
24
to sequence the genome of circulating strains of the 
25
20:37 Feb 28, 2021
H791
4 
•HR 791 IH
SARS–CoV–2 virus, to identify mutations in the 
1
SARS–CoV–2 virus, to use genomic sequencing to 
2
identify outbreaks and clusters of COVID–19 infec-
3
tions caused by specific variants of SARS–CoV–2, 
4
and to develop effective COVID–19 response strate-
5
gies based on genetic sequencing and surveillance 
6
data; and 
7
(3) carry out activities to both enhance the 
8
informatics capabilities of the public health work-
9
force and expand the numbers of qualified public 
10
health informaticians available to analyze and inter-
11
pret data produced through advanced molecular de-
12
tection and genomic sequencing to establish, expand, 
13
or enhance capacity for conducting statistical public 
14
health research. 
15
(c) IMPLEMENTATION.— 
16
(1) COOPERATIVE
AGREEMENTS
FOR
TECH-
17
NICAL
ASSISTANCE.—Cooperative agreements de-
18
scribed in subsection (b)(2) may include partner-
19
ships with academic research institutions. 
20
(2) CAPACITY FOR SHARING AND LINKING.— 
21
The capacity referred to in subsection (b)(3) may in-
22
clude sharing and linking information and accessing 
23
and utilizing linked health data files in accordance 
24
with established data use agreements with data hold-
25
20:37 Feb 28, 2021
H791
5 
•HR 791 IH
ers (including electronic case reporting, electronic 
1
health records, and electronic test orders and re-
2
sults) with public health agencies and related sys-
3
tems, including the National Death Index, immuni-
4
zation information systems, syndromic surveillance 
5
systems, laboratory information management sys-
6
tems, electronic case reporting systems, medical ex-
7
aminer case management systems, and Patient Uni-
8
fied Look-up Systems for Emergencies. 
9
(d) FACILITIES.—Funds appropriated under sub-
10
section (f) may be used for grants for the construction, 
11
alteration, or renovation of non-federally owned facilities 
12
to improve genetic sequencing and surveillance capabilities 
13
at the State and local level. 
14
(e) EXPANSION
OF ONGOING ACTIVITIES.—Funds 
15
appropriated under subsection (f) may be used for grants 
16
for the maintenance and expansion of current and ongoing 
17
activities to analyze and interpret data produced through 
18
advanced molecular detection and genomic sequencing, in-
19
cluding for emerging public health threats. 
20
(f) AUTHORIZATION OF APPROPRIATIONS.—There is 
21
authorized to be appropriated, $2,000,000,000 for fiscal 
22
year 2021 to carry out this section, to remain available 
23
until expended. 
24
20:37 Feb 28, 2021
H791
6 
•HR 791 IH
SEC. 5. EVIDENCE-BUILDING DEMONSTRATION PROGRAM. 
1
(a) IN GENERAL.—The Secretary, acting through the 
2
Director of the National Center for Health Statistics, shall 
3
carry out a demonstration program to expand the data 
4
linkage program of the Department of Health and Human 
5
Services, consisting of Federal statistical and pro-
6
grammatic datasets from specified Federal entities, as au-
7
thorized by subchapter III of chapter 35 of title 44, 
8
United States Code, for the purpose of facilitating statis-
9
tical public health research on trends and patterns across 
10
specifically defined, statistically relevant populations, with 
11
a particular focus on linking social determinants of health 
12
data, including with respect to— 
13
(1) food insecurity; 
14
(2) housing instability; 
15
(3) transportation access; 
16
(4) safety; 
17
(5) social connection and isolation; 
18
(6) financial resource strain; 
19
(7) stress; 
20
(8) race and ethnicity; and 
21
(9) sexual orientation and gender identity. 
22
(b) ACTIVITIES.—Activities carried out under the 
23
demonstration program under this section shall include— 
24
(1) assessing the availability of identified and 
25
de-identified data sets held by Federal, State, local, 
26
20:37 Feb 28, 2021
H791
7 
•HR 791 IH
and non-Federal entities that may be useful for re-
1
search described in subsection (a); and 
2
(2) using existing authorities and linkages of 
3
data in accordance with subchapter III of chapter 35 
4
of title 44, United States Code, when relevant to re-
5
quest the submission of datasets to the National 
6
Center for Health Statistics for linking. 
7
(c) LIMITATION.—The Secretary shall limit access to 
8
data under the demonstration program under this sec-
9
tion— 
10
(1) to Federal statistical agencies and qualified 
11
public and private researchers, as determined by the 
12
Director of the National Center for Health Statis-
13
tics; 
14
(2) for a period to be specified by the Sec-
15
retary; and 
16
(3) exclusively for the purpose described in sub-
17
section (a). 
18
(d) PROCESS FOR MAKING DATA AVAILABLE.— 
19
(1) IN GENERAL.—Consistent with paragraph 
20
(2), the Secretary shall establish a rigorous process 
21
for making data available and usable under the dem-
22
onstration program under this section. 
23
(2) REQUIREMENTS.—Prior to making any 
24
data available under the demonstration program 
25
20:37 Feb 28, 2021
H791
8 
•HR 791 IH
under this section, by an entity described in sub-
1
section (b)(1) to another entity described in sub-
2
section (b)(1)— 
3
(A) the receiving entity shall submit to the 
4
Director of the National Center for Health Sta-
5
tistics an application for data for the purpose 
6
described in subsection (a); and 
7
(B) the Director shall approve or deny 
8
such request in writing, including in the case of 
9
a denial an explanation of the reasons for the 
10
denial. 
11
(e) RULEMAKING.— 
12
(1) NO
DELAY
ON
IMPLEMENTATION.—The 
13
Secretary— 
14
(A) shall begin the implementation of the 
15
demonstration program under this section upon 
16
the date of enactment of this Act; and 
17
(B) shall not delay such implementation 
18
for purposes of promulgating the regulations re-
19
quired by paragraph (2). 
20
(2) PROMULGATION.—The Secretary shall— 
21
(A) promulgate regulations for carrying 
22
out this section; and 
23
(B) specify in such regulations the allowed 
24
and disallowed purposes for sharing and linking 
25
20:37 Feb 28, 2021
H791
9 
•HR 791 IH
data through the program, including areas of 
1
potential research. 
2
(f) WEBSITE.—The Secretary shall maintain a pub-
3
licly accessible website— 
4
(1) providing information about demonstration 
5
program under this section; 
6
(2) facilitating stakeholder participation in such 
7
demonstration program; 
8
(3) facilitating oversight of such demonstration 
9
program; 
10
(4) providing lists of datasets from Federal and 
11
non-Federal entities; 
12
(5) providing lists of identified and de-identified 
13
datasets; 
14
(6) identifying linked datasets; 
15
(7) delineating a process to protect privacy and 
16
confidentiality; 
17
(8) identifying sources of the datasets; and 
18
(9) delineating categories of personal data. 
19
(g) PROGRAM REQUIREMENTS.—The demonstration 
20
program under this section shall be designed to— 
21
(1) support data matching services for agencies 
22
and researchers using the National Death Index; 
23
and 
24
20:37 Feb 28, 2021
H791
10 
•HR 791 IH
(2) facilitate collaboration with States and pri-
1
vate entities to examine, update, and modernize the 
2
fee structure of the National Death Index to support 
3
a broad range of data queries. 
4
(h) CONTRACTED ENTITIES.— 
5
(1) IN GENERAL.—Subject to the availability of 
6
appropriations, the Secretary may enter into con-
7
tracts with eligible entities, as appropriate, for infra-
8
structure and support services in carrying out the 
9
demonstration program under this section. 
10
(2) ELIGIBILITY.—To be eligible for a contract 
11
under paragraph (1), an entity shall— 
12
(A) demonstrate core capabilities for data 
13
sharing, data linkage, and compliance with sub-
14
chapter III of chapter 35 of title 44, United 
15
States Code; and 
16
(B) adhere to security standards in accord-
17
ance with the Federal Risk and Authorization 
18
Management Program (or any successor pro-
19
gram). 
20
(i) RULE OF CONSTRUCTION.—Nothing in this sec-
21
tion shall be construed to authorize the availability or use 
22
of data for— 
23
(1) law enforcement; or 
24
20:37 Feb 28, 2021
H791
11 
•HR 791 IH
(2) any determination of the eligibility of an in-
1
dividual for any direct or indirect payment, benefit, 
2
or service. 
3
(j) REPORT TO CONGRESS.—Not later than 1 year 
4
after the date of enactment of this Act, and annually 
5
thereafter, the Secretary shall submit a report to the Con-
6
gress on the implementation of this section, including— 
7
(1) identification of best State practices for— 
8
(A) sharing data with, and reporting data 
9
to, the National Death Index; and 
10
(B) ensuring the quality of such data; and 
11
(2) recommendations to improve— 
12
(A) such sharing and reporting; and 
13
(B) access to the National Death Index by 
14
researchers. 
15
(k) AUTHORIZATION OF APPROPRIATIONS.—There is 
16
authorized to be appropriated to carry out this section, 
17
$10,000,000 for fiscal year 2021, to remain available until 
18
expended. 
19
Æ 
20:37 Feb 28, 2021
H791
